Immunotherapy in HCC: Selecting the Right Option for the Right Patient

Dina Ioffe, MD, Fox Chase Cancer Center, discusses using immunotherapy in the neoadjuvant, adjuvant, and other settings to treat patients with advanced hepatocellular carcinoma.

She shares how clinicians can select the right patients for the right treatment and what future research still needs to be done.

Видео Immunotherapy in HCC: Selecting the Right Option for the Right Patient канала GI Oncology Now